An open, randomised, multicentre trial of Tomudex (ZD1694) versus 5-Fluorouracil (5-FU) and Leucovorin (LV) in patients with advanced colorectal carcinoma Not provided at time of registration

• Country United Kingdom
• organs None
• Specialty None

A Prospective Randomised Comparison of CMF versus Sequential Epirubicin Followed by CMF as Adjuvant Chemotherapy for Women with Early Breast Cancer http://cancerhelp.cancerresearchuk.org/trials/national-breast-cancer-study-of-epirubicin-as-adjuvant-therapy

• Country United Kingdom
• organs None
• Specialty None

Randomised comparison of cyclical anthracyline-based chemotherapy [PA(B1)OE] with alternating chemotherapy [Ch1VPP/PABLOE] in advanced Hodgkin's disease Not provided at time of registration

• Country None
• organs None
• Specialty None

High Dose Therapy in Poor-Risk Primary Breast Cancer Not provided at time of registration

• Country None
• organs None
• Specialty None

An open randomised study of the efficacy of standard radiotherapy with and without the addition of SRL172 (Mycobacterium vaccae) in the treatment of patients with small cell lung cancer (SIRON 13) Not provided at time of registration

• Country United Kingdom
• organs None
• Specialty None

Adjuvant cyclophosphamide, methotrexate and 5-Fluorouracil (CMF) versus 5-Fluorouracil, epirubicin and cyclosphosphamide (FEC) in node negative poor-risk primary breast cancer Not provided at time of registration

• Country None
• organs None
• Specialty None

Trial of PACEBOM versus CHOP in histologically aggressive non-Hodgkins lymphoma Not provided at time of registration

• Country None
• organs None
• Specialty None

A randomised study of continuous infusional 5-Fluorouracil (5FU) with or without bolus mitomycin-C in patients with carcinoma of unknown primary origin Not provided at time of registration

• Country United Kingdom
• organs None
• Specialty None

Medical Research Council/ European Blood and Marrow Transplant Prospective Randomised Trial of Autograft in Chronic Myeloid Leukaemia (CML) Not provided at time of registration

• Country United Kingdom
• organs None
• Specialty None

Double-blind, placebo-controlled, randomised phase 2 trial of IH636 grape seed proanthocyanidin (GSPE) in patients with adverse effects of high dose breast radiotherapy http://cancerhelp.cancerresearchuk.org/trials/using-ih636-grape-seed-extract-to-reduce-side-effects-of-high-dose-radiotherapy-for-breast-cancer

• Country None
• organs None
• Specialty None